BMJ 1995;311:451 (12 August)
Letters
General practitioners would expect to see aplasia roughly once each century
EDITOR,--Although chloramphenicol eye drops may induce bone marrow aplasia, it might be helpful to put the risk in perspective.1 In our practice of 4600 patients we use chloramphenicol eye drops as our first line treatment for conjunctivitis and after removal of foreign bodies. We also frequently prescribe chloramphenicol drops on the advice of local ophthalmologists. In total, we issue 360 prescriptions for chloramphenicol drops or ointment a year. Assuming that the risk of aplastic anaemia after topical administration is the same as that after oral administration, we would expect to see one case every 83-138 years in the practice as a whole, or one case every 240-400 years per general practitioner.
General practitioner General practitioner Caldbeck Surgery, Caldbeck, Wigton, Cumbria CA7 8DS
Jim Cox,
Eleri M Roderick
- Doona M, Walsh JB. Use of chloramphenicol as topical eye medication: time to cry halt? BMJ 1995;310:1217-8. (13 May.)